Global Allergy Immunotherapy Market, by Treatment Type (Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT)), by Allergy Type (Allergic Rhinitis, Allergic Asthma, Food Allergy, Venom Allergy, and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 2,116.0 million in 2022 and expected to exhibit a CAGR of 9.3% over the forecast period (2022-2030), as highlighted in a new report published by Coherent Market Insights.
Increasing approval of immunotherapy by regulatory authority is expected to drive the market growth over the forecast period.
For instance, in 2014, Stallergenes S.A., a healthcare company manufacture the allergy immunotherapy product has received the U.S. Food and Drug Administration approval for ORALAIR(R), for the treatment of grass pollen-induced allergic rhinitis with or without conjunctivitis.
For instance, in February 2020, Aimmune Therapeutics a biopharmaceutical company, received the U.S. Food and Drug Administration approval for its AR101 (Palforzia) oral peanut-protein immunotherapy for indication of food allergy.
Global Allergy Immunotherapy Market – COVID-19 Impact (Demand and Supply Chain Analysis)
The COVID-19 pandemic and lockdown in various countries across the globe have impacted the financial status of businesses across all sectors. The private healthcare sector is one such sector which has been majorly impacted by the pandemic.
Moreover, the coronavirus pandemic has negatively impacted the supply of raw materials required for the production of health supplements including brain health supplements, across the globe.
Furthermore, COVID-19 pandemic has affected the economy in three main ways; 1) by directly affecting the production and demand; 2) by creating disruptions in distribution channels; and 3) through its financial impact on companies and financial markets.
Several manufacturers are facing issues such as shortage of labor and transportation of raw materials, which has affected the production of the immunotherapy. Most of the vehicles used for transportation of these products are stuck at the states borders or at the country’s borders.
Browse 29 Market Data Tables and 31 Figures spread through 154 Pages and in-depth TOC on “Allergy Immunotherapy Market”- Global Forecast to 2030 by Treatment Type (Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT)), by Allergy Type (Allergic Rhinitis, Allergic Asthma, Food Allergy, Venom Allergy, and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
To know the latest trends and insights prevalent in the Global Allergy Immunotherapy Market, click the link below:
https://www.coherentmarketinsights.com/market-insight/allergy-immunotherapy-market-4915
Factors such as increasing strategic collaborations and partnerships by key players to expand their presence are expected to drive the global allergy immunotherapy market growth.
For instance, in October 2021, Aptar Pharma, a drug delivery system, service and active material solution provider, entered into partnership with Stallergenes Greer, a healthcare company specializing in allergen immunotherapy, for the development of a new connected drug delivery device and companion mobile app.
Key Takeaways of the Global Allergy Immunotherapy Market:
- The global allergy immunotherapy market is expected to exhibit a CAGR of 9.3% over the forecast period, owing to increasing prevalence of asthma. For instance, according to the Centers for Disease Control and Prevention (CDC), about 27 million people in the U.S. were suffering from asthma in 2016. Moreover, it is the most common chronic condition among the U.S. children, where one child out of every 12 has asthma.
- Among treatment type, subcutaneous immunotherapy segment is expected to account for the largest market share in 2022, owing to the most commonly used and most effective form of allergy immunotherapy, this is the only treatment for allergy immunotherapy which actually changes the immune system of a patient.
- Key players operating in the global allergy immunotherapy market include Stallergenes Greer, ALK-Abello A/S, Allergy Therapeutics, Allergopharma, HAL Allergy Group, Aimmune Therapeutics, DBV Technologies, Leti Pharma, and Jubilant HollisterStier
